Dermatology

ANAPTYSBIO, INC

12/9/21 → 12/31/26

Project: Research project

Coordinating Investigator Agreement

Pearson, D. R.

EMD Serono, Inc.

11/1/21 → 11/1/24

Project: Research project

A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY ANDEFFICACY OF CTP-543 IN ADULT PATIENTS WITHMODERATE TO SEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

5/20/21 → 5/31/26

Project: Research project

A STUDY TO EVALUATE MAINTENANCE OF HAIR REGROWTH FOLLOWINGDOSE REDUCTION OF CTP-543 IN ADULT PATIENTS WITH MODERATE TOSEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

3/1/21 → 3/30/26

Project: Research project

PHASE 2 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS

Pearson, D. R.

1/19/21 → 1/31/25

Project: Research project

Measuring Alopecia Areata Patient-Reported Psychosocial Outcomes: Scale Development and Validation

10/7/20 → 1/31/23

Project: Research project

An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904to Evaluate the Safety, Tolerability, and Efficacy of EfgartigimodPH20 SC in Patients With Pemphigus

Argenx

9/17/20 → 9/30/25

Project: Research project

A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy,Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderateor Severe Pemphigus (Vulgaris or Foliaceus)

Argenx

8/19/20 → 8/30/25

Project: Research project

A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome)

Maher, I.

PELLEPHARM, INC.

5/18/20 → 5/31/25

Project: Research project

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study, with a 28-Week Open-Label Extension, to Assess the Safety and Efficacy of Etrasimod in Subjects with Moderate-to-Severe AlopeciaAreata

ARENA PHARMACEUTICALS, INC.

5/14/20 → 5/31/25

Project: Research project

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA

Concert Pharmaceuticals, Inc.

5/1/20 → 7/30/25

Project: Research project

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-MediatedInflammatory Skin Conditions

TARGET PHARMASOLUTIONS, INC

4/6/20 → 4/30/25

Project: Research project

A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF-06650833, PF-06700841, AND PF-06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA

Goldfarb, N.

Vogel, R. & Ahmed-Saucedo, R. L.

1/10/20 → 1/30/25

Project: Research project

A Phase 2, Multicenter,Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab inAdult Subjects with Moderate to Severe Hidradenitis Suppurativa

Goldfarb, N.

AbbVie

8/8/19 → 8/30/24

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group,Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan inSubjects with Moderate to Severe Hidradenitis Suppurativa

Goldfarb, N.

ChemoCentryx, Inc.

8/1/19 → 8/30/24

Project: Research project

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

AMERICAN CANCER SOCIETY, INC.

7/1/19 → 6/30/23

Project: Research project

A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY ANDSAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSIONPERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 ANDPF-067008

6/20/19 → 6/30/24

Project: Research project

A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

6/17/19 → 6/30/24

Project: Research project

Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

Maher, I.

CASTLE BIOSCIENCES, INC.

2/6/19 → 2/29/24

Project: Research project

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)

ACLARIS THERAPEUTICS, INC

1/4/19 → 1/31/24

Project: Research project

A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

10/9/18 → 10/30/23

Project: Research project

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-monthOpenlabelFollow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa

AMRYT RESEARCH, LTD

8/30/18 → 8/30/23

Project: Research project

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study ofPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal CellCarcinomas (BCCs) in Subjects with Basal Cell Nevus

Maher, I.

PELLEPHARM, INC.

8/27/18 → 8/31/23

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Eli Lilly G.m.b.H.

8/6/18 → 8/30/23

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

ACLARIS THERAPEUTICS, INC

6/15/18 → 6/30/22

Project: Research project

An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6months to < 18 years of age with Atopic Dermatitis

Maguiness, S.

Regeneron Pharmaceuticals, Inc.

11/1/17 → 11/30/22

Project: Research project

A double-blind, randomized, vehicle controlled, crossove

Regeneron Pharmaceuticals, Inc.

ELORAC INC

10/1/17 → 2/20/24

Project: Research project

A Phase 2/3 Study Investigation the Phamacokinetics, Saf

Maguiness, S.

2/1/17 → 2/28/23

Project: Research project

Mechanism of immune modulation by DPCP in alopecia

NATIONAL ALOPECIA AREATA FOUNDATION

1/1/16 → 6/30/22

Project: Research project

Finished

Developing the next generation of safer 2-in-1 hair dye products

Bigliardi, P. L.

National University of Singapore

12/1/19 → 3/31/22

Project: Research project

The Impact of Pediatric Skin Disorders: The "Big" Study

Boull, C. L.

Northwestern University

9/13/19 → 12/31/20

Project: Research project

A Multi-center Study to Evaluate the Pharmacokinetics ofDiacerein and Rhein and the Safety of Diacerein after MaximumUse, Topical Administration of CCP-020 (Diacerein 1%ointment) to Patients with Epidermolysis Bullosa (EB)

CASTLE CREEK PHARMACEUTICALS, LLC

1/21/19 → 7/31/19

Project: Research project

An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

CASTLE CREEK PHARMACEUTICALS, LLC

1/1/19 → 7/31/19

Project: Research project

Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

Hordinsky, M. K. & Berge, J. M.

SOLIGENIX INC

11/27/18 → 5/6/22

Project: Research project

Intergrated Behavioral Healthcare in Dermatology: A C-Located Care Pilot Study.

University of Wisconsin-Stout

10/1/18 → 9/30/19

Project: Research project

WEN Shampoo Study

Farah, R. S. & Hordinsky, M. K.

CHAZ DEAN, INC.

8/27/18 → 10/31/21

Project: Research project

Cutaneous T-Cell Lymphoma study

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/18 → 9/30/19

Project: Research project

Epidermolysis Bullosa Clinical Characterization and Outc

Hook, K. P. & Boull, C. L.

EPIDERMOLYSIS BULLOSA MED RESEARCH FOUND

8/24/17 → 6/30/18

Project: Research project

An International, Multicenter, Randomized, Double-Blind,

MEDPACE, INC.

8/1/17 → 8/30/21

Project: Research project

A Randomized, Double-blind, Vehicle-controlled

ACLARIS THERAPEUTICS, INC

8/1/17 → 8/30/21

Project: Research project

Characteristics of patients with mycosis fungoides/Sezar

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/17 → 6/30/18

Project: Research project

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

6/21/17 → 1/30/22

Project: Research project

Severity and Culture Status in Epidermolysis Bullosa wit

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

3/1/17 → 12/31/19

Project: Research project

Program for Innovative Continuing Medical Education in D

Hurliman, E. & Reich, H. C.

AMERICAN ACADEMY OF DERMATOLOGY

1/1/17 → 12/31/18

Project: Research project

Allogeneic skin grafting in the treatment of chronic

Shih, T. L. & Miller, D. D.

WOMEN'S DERMATOLOGIC SOCIETY

7/15/16 → 7/14/19

Project: Research project

Cutaneous Findings in Fanconi Anemia and Patient Percept

Boull, C. L., Hook, K. P., Maguiness, S. & Polcari, I. C.

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

7/1/16 → 12/31/17

Project: Research project

Cannabinoid-based therapy and approaches to quantify pai

Gupta, K., Bagchi, A., Connett, J. E., Datta, Y. H., Ericson, M. E., He, B., Honda, C. N., Simone, D. A. & Ugurbil, K.

National Institutes of Health (NIH)

6/1/16 → 5/31/19

Project: Research project

An Open Label Multi-Center Extension Study to Evaluate

SCIODERM, INC.

4/22/16 → 4/30/20

Project: Research project

A Phase 3, Multi-center, Randomized, Double-Blind